Profile data is unavailable for this security.
About the company
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. is principally engaged in the research & development, production and sales of veterinary biological products. The Company’s products mainly include escherichia coli (K88 and K99) gene modified vaccines for piglets, inactivated; porcine reproductive and respiratory syndrome vaccines, live and swine infectious atrophic rhinitis vaccines, inactivated; newcastle disease mild vaccines, living; newcastle disease, infectious bronchitis, egg drop syndrome’76 vaccines, inactivated and infectious bronchitis vaccines, living, among others. The Company distributes its products mainly in China.
- Revenue in CNY (TTM)239.79m
- Net income in CNY44.92m
- Incorporated1981
- Employees295.00
- LocationShanghai Hile Bio-Technology Co LtdNo. 6720Jinhai Highway, Fengxian DistrictSHANGHAI 200021ChinaCHN
- Phone+86 2 160890892
- Fax+86 2 160890800
- Websitehttp://www.hile-bio.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jinyao Pharmaceutical Co Ltd | 3.66bn | 107.59m | 3.82bn | 2.68k | 35.46 | 1.26 | -- | 1.04 | 0.0984 | 0.0984 | 3.35 | 2.76 | 0.5738 | 2.28 | 9.37 | 1,365,219.00 | 2.33 | 1.91 | 4.17 | 3.40 | 42.61 | 46.33 | 4.06 | 3.31 | 0.7584 | 27.18 | 0.2064 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
Zhejiang Starry Pharmaceutical Co Ltd | 2.27bn | 46.95m | 3.93bn | 1.85k | 65.57 | 1.74 | -- | 1.73 | 0.1368 | 0.1368 | 6.63 | 5.15 | 0.4179 | 1.98 | 5.09 | 1,231,642.00 | 0.8789 | 3.30 | 1.80 | 5.97 | 23.86 | 32.35 | 2.10 | 8.21 | 0.4121 | 1.44 | 0.6405 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 3.99bn | 295.00 | 90.58 | 3.19 | -- | 16.63 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.02bn | 4.14k | 20.26 | 1.38 | -- | 1.39 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 4.04bn | 1.45k | 16.54 | 1.99 | -- | 4.55 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 4.17bn | 760.00 | 32.56 | 1.41 | -- | 3.76 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.84bn | 322.70m | 4.21bn | 5.34k | 13.15 | 1.70 | -- | 1.10 | 0.7546 | 0.7546 | 8.94 | 5.82 | 0.8283 | 3.58 | 9.76 | 719,592.90 | 8.61 | 8.99 | 16.26 | 16.21 | 45.46 | 44.59 | 10.40 | 10.03 | 1.95 | -- | 0.1297 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
Data as of Jul 26 2024. Currency figures normalised to Shanghai Hile Bio-Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.33%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Guotai Asset Management Co., Ltd.as of 31 Dec 2023 | 5.05m | 0.78% |
Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 2.08m | 0.32% |
Gfund Management Co., Ltd.as of 31 Dec 2023 | 2.00m | 0.31% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 1.76m | 0.27% |
Penghua Fund Management Co., Ltd.as of 31 Dec 2023 | 1.18m | 0.18% |
China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 838.10k | 0.13% |
China Asset Management Co., Ltd.as of 31 Dec 2023 | 579.50k | 0.09% |
Tian Hong Asset Management Co., Ltd.as of 31 Dec 2023 | 551.50k | 0.09% |
China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 467.80k | 0.07% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 460.90k | 0.07% |
More ▼
Data from 31 Dec 2023 - 27 Jun 2024Source: FactSet Research Systems Inc.